382 related articles for article (PubMed ID: 3426929)
21. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.
Brooks SA; Leathem AJ; Camplejohn RS; Gregory W
Breast Cancer Res Treat; 1993; 25(3):247-56. PubMed ID: 8369526
[TBL] [Abstract][Full Text] [Related]
22. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of ploidy of primary tumour and nodal secondaries in colorectal cancers.
Zoras OI; Curti G; Cooke TG; Vlachonikolis IG; Forster G; McArdle CS; Stanton PD
Surg Oncol; 1994 Dec; 3(6):345-9. PubMed ID: 7773451
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
[TBL] [Abstract][Full Text] [Related]
26. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.
Beerman H; Kluin PM; Hermans J; van de Velde CJ; Cornelisse CJ
Int J Cancer; 1990 Jan; 45(1):34-9. PubMed ID: 2298504
[TBL] [Abstract][Full Text] [Related]
28. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
30. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of ploidy analysis in operable breast cancer.
Sharma S; Mishra MC; Kapur BM; Verma K; Nath I
Cancer; 1991 Dec; 68(12):2612-6. PubMed ID: 1933810
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
Lewis WE
Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
[TBL] [Abstract][Full Text] [Related]
33. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
35. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
Kenter GG; Cornelisse CJ; Aartsen EJ; Mooy W; Hermans J; Heintz AP; Fleuren GJ
Gynecol Oncol; 1990 Nov; 39(2):181-5. PubMed ID: 2227593
[TBL] [Abstract][Full Text] [Related]
37. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
38. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
[TBL] [Abstract][Full Text] [Related]
39. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
